Key result
Cardiac VEGF-B overexpression in mice induced a distinct electrophysiological phenotype characterized by increased QRSp time, decreased S and R amplitudes, and prolonged action potential duration due to downregulation of sodium and potassium currents.
Cardiac VEGF-B overexpression in mice induces significant electrophysiological remodeling, altering action potential waveforms and ECGs without affecting contractile function or energy metabolism.
Hypothesis-generating in mice; leaves open whether VEGF-B alters human electrophysiology or arrhythmia risk.
Vascular endothelial growth factor B (VEGF-B) is a potent mediator of vascular, metabolic, growth and stress responses in the heart, but the effects on cardiac muscle and cardiomyocyte function are not known. The purpose of this study was to assess the effects of VEGF-B on the energy metabolism, contractile and electrophysiological properties of mouse cardiac muscle and cardiac muscle cells. In vivo and ex vivo analysis of cardiac-specific VEGF-B TG mice indicated that the contractile function of the TG hearts was normal. Neither the oxidative metabolism of isolated TG cardiomyocytes nor their energy substrate preference showed any difference to WT cardiomyocytes. Similarly, myocyte Ca2+ signalling showed only minor changes compared to WT myocytes. However, VEGF-B overexpression induced a distinct electrophysiological phenotype characterised by ECG changes such as an increase in QRSp time and decreases in S and R amplitudes. At the level of isolated TG cardiomyocytes, these changes were accompanied with decreased action potential upstroke velocity and increased duration (APD60-70). These changes were partly caused by downregulation of sodium current (INa) due to reduced expression of Nav1.5. Furthermore, TG myocytes had alterations in voltage-gated K+ currents, namely decreased density of transient outward current (Ito) and total K+ current (Ipeak). At the level of transcription, these were accompanied by downregulation of Kv channel-interacting protein 2 (Kcnip2), a known modulatory subunit for Kv4.2/3 channel. Cardiac VEGF-B overexpression induces a distinct electrophysiological phenotype including remodelling of cardiomyocyte ion currents, which in turn induce changes in action potential waveform and ECG.
No takes yet. Share an insight, caveat, or question.
Naumenko et al. (2017) studied Cardiac electrophysiology. VEGF-B overexpression vs. Wild-type littermates was evaluated on Electrophysiological properties (ECG and action potential waveform). Cardiac VEGF-B overexpression in mice induced a distinct electrophysiological phenotype characterized by increased QRSp time, decreased S and R amplitudes, and prolonged action potential duration due to downregulation of sodium and potassium currents.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: